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This article studies a contemporary treatment approach toward both diabetes and depression managementby vanadium-enriched
Cordyceps sinensis (VECS). Streptozotocin-induced hyperglycemic rats were used in the study. After the rats were administered
withVECS, a signiﬁcantreduction inblood glucose levels was seen (P < .05) andthe levels ofserum insulin increased signiﬁcantly
(P < .05).At the sametime, the study revealed a signiﬁcantdecrease in immobilitywitha corresponding increase in the swimming
and climbing behavior in hyperglycemic rats following VECS treatment. The results described herein demonstrate that VECS is a
contemporary treatment approach that advocates an aggressive stance toward both diabetes and depression management.
1.Introduction
Diabetes mellitus is accompanied by hormonal and neuro-
chemical changes that can be associated with anxiety and
depression [1, 2]. The prevalence of depression is ∼18%
higher in diabetic patients than in the general population,
and only 33% of depression cases among diabetic patients
are diagnosed and treated [3, 4].These associations may
be related to increased risk of depressive symptoms in
individuals with diabetes, increased risk of type 2 diabetes
in individuals with depressive symptoms or both. Growing
evidence from clinical studies indicates that diabetic patients
with major depression demonstrate poor adherence to
antidiabetic regimens, have poor glycemic control and are
at increased risk of retinopathy [5] and macrovascular
complications [6].
The two processes of diabetes and depression nega-
tively interact, in that depression leads to poor metabolic
control whereas hyperglycemia exacerbates depression. A
contemporary treatment approach advocates an aggressive
stance toward both diabetes and depression management
to optimize global outcome. To our knowledge, however,
an algorithm incorporating the management of both has
not been discovered in the literature. Thus, the present
study was carried out to investigate the possible role of
vanadium-enriched Cordyceps sinensis (VECS)in preventing
depression in diabetes and inﬂuencing the longer-term
course of glycemic control. One novel vanadium complex of
VECS is designed and evaluated in this article.
As a potential therapeutic agent, vanadium has been
attracting increasing attention. Vanadium compounds have
the ability to imitate the action of insulin [7], and oral
administration of inorganic vanadium salts has shown
anti-diabetic activity in vitro [8], in vivo [9]a n de v e n
in patients [10]. However, the toxicity associated with
vanadium limits its role as a therapeutic agent for diabetic
treatment [11]. Typical clinical manifestations are diarrhea,
vomiting, abdominal cramps, green tongue, bronchospasm
and irreversible renal excretion damage [12]. Using trace
elements at lower doses, in combination with fungus, has
been ascribed as one potent way to reduce toxicity associated
with trace elements and maintain their eﬀect [13, 14].
Mushrooms and primarily basidiomycetous fungi are
popular and valuable foods that are low in calories and
high in minerals, essential amino acids, vitamins and ﬁbers
[15, 16]. With no starch and low sugars, mushrooms might
be considered the “delight of diabetics” [17]. Some of them
produce substances with potential medical eﬀects, and are
called medicinal mushrooms [18–21].2 Evidence-Based Complementary and Alternative Medicine
Table 1: Eﬀect of VECS on and other treatments on serum glucose
levels in streptozotocin-hyperglycemic rats.
Diﬀerent groups Serum glucose (mgdl−1)
Streptozotocin treated 231.9 ± 36.7a
Streptozotocin and SV treated 178.8 ± 10.6a
Streptozotocin and FMCS treated 183.2 ± 11.4a
Streptozotocin and VECS treated 95.8 ± 8.9b
Control group 100.9 ± 6.8b
Values are mean ± SEM. Number of animals = 6. Superscript letters in the
same column indicate a statisticaldiﬀerence of P<. 05.
Cordyceps sinensis i saf u n g u sk n o w na sat r a d i t i o n a l
medicine in China. Many studies have shown that C. sinensis
possesses hypoglycemic [22, 23] and vasorelaxant properties
[24]. Another important property of fungus is the ability to
take up and accumulate trace metals such as cadmium, lead,
arsenic, copper, nickel, silver, chromium and mercury in the
body ormyceliumofthefungus[25–27].The purposeofthis
study was to investigate the eﬀect of fermented fungus of C.
sinensis that is rich in vanadium on depression in diabetes
and its inﬂuence on the course of glycemic control.
2.Methods
2.1. Chemicals. Streptozotocin (analytical grade) was pur-
chased from Sigma. Sodium vanadate (SV; analytical grade)
was purchased from Beijing Chemical Factory, China.
2.2. VECS. The seed of C. sinensis was purchased from the
AgriculturalCultureCollectionofChina.Firstly,theseedwas
grownat28
◦Cfor5daysonPDAslants(1000mL20%potato
extract liquid, 20.0g dextrose and 20.0g agar). Mycelia of C.
sinensis (ﬁve to six pieces) were transferred from a slant into
250mL Erlenmeyer ﬂasks containing 100mL liquid medium
(20% potato extract liquid, 2.0% dextrose, 0.1% KH2PO4
and 0.05% MgSO4). The culture was incubated at 27◦Co n
a rotary shaker at 180rmp for 4 days.
A 96-h-old liquid culture was homogenized using a
sterilized blender and then inoculated to 500mL Erlenmeyer
ﬂaskscontaining300mL offermentedculturemedium(20%
potato extract liquid, 2.0% dextrose, 0.1% KH2PO4, 0.05%
MgSO4 and 0.9% NaVO3). The volume of inoculum was
15mL, which was then cultivated under the same condition.
The 96-h-oldfermentedliquidcultureconstitutedtheVECS.
An ampule was ﬁlled with 4mL of VECS stirred by a
homogenizer and then was sterilized in microwave oven for
3min. The concentration of vanadate in VECS was 0.074M.
2.3. Fermented Mushroom of C. sinensis. The fermented
mushroom of C. sinensis (FMCS) was produced using the
same method to produce VECS except that there was no
NaVO3 in the fermented culture medium.
2.4. SV Solution. SV (0.9g) was dissolved in 100mL of
normal saline. An ampule was ﬁlled with 4mL of SV and
Table 2: Eﬀect of VECS on serum insulin level in streptozotocin-
induced diabetic rats.
Diﬀerent groups Serum insulin (IUmL−1)
Streptozotocin treated 12.9 ± 1.7a
Streptozotocin and SV treated 11.4 ± 1.6a
Streptozotocin and FMCS treated 15.57 ± 2.1b
Streptozotocin and VECS treated 16.69 ± 3.3b
Saline treated 19.26 ± 2.4b
Values are mean ± SEM. Number of animals = 6. Superscript letters in the
same column indicate a statisticaldiﬀerence of P<. 05.
then was sterilized in a microwave oven for 3min. The
concentration of vanadate in SV was 0.074M.
2.5. Animals. This study was performed in accordance
with the Guidelines for Ethical Conduct in the Care and
Use of Animals developed by the American Psychological
Association (APA). Care was taken to minimize discomfort,
distress and pain to the animals. Wistar rats of either sex
weighing 150–200g were housed in polypropylene cages (six
animals/cage) under controlled temperature (27 ± 2◦C) and
in a natural light/dark cycle. They were fed with standard
laboratory pellets. Food and water were provided ad libitum.
2.6. Drugs and Treatment. Healthy rats were made diabetic
by intraperitoneal injection of streptozotocin (55mgkg−1).
Serum glucose levels were measured 7 days after the injec-
tion. A total of 24 animals showing hyperglycemia were
selected as diabetic rats. They were randomly divided into
four groups. From then on, the four groups of rats were
treated daily (by oral gavage) with 4mL of saline, VECS,
FMCS and SV, respectively. The other six normal rats were
treated daily (by oral gavage) with 4mL of saline and used
as the control group. At the end of the treatment (4 weeks
later), the rats were fasted for 12h, blood samples were
collected from the tail vein and serum was separated. The
blood glucose was analyzed with a Glucometer-4 (Bayer).
Serum insulin level was determined with an enzyme-linked
immunosorbant assay (ELISA) kit (Biosource, Europe).
Five weeks after diabetes induction, the rats were sub-
mitted to the forced swimming test [28]. Brieﬂy, the rats
were forced to swim individually in a cylinder (40cm height,
15cm diameter) containing fresh water (temperature 22 ±
2◦C) up to a height of 30cm for 15min. This constituted
the “pre-test”swim. Twenty-four hours later, each rat wasre-
exposedtotheswimming conditioninasimilar environment
in a 6-min “test session”. The total duration of climbing,
swimming and immobility in the last 5min of the 6-min
test session was recorded for each animal. The animals
were treated with 4mL of saline, VECS, FMCS and SV,
respectively, 30min prior to the test session.
Climbing behavior consisted of upward directed move-
ments of the forepaws along the side of the swim chamber.
Swimming behavior was deﬁned as movement (usually
horizontal) throughout the swim chamber, and immobility
was assigned when no additional activity was observed other
than that required to keep the rat’s head above water.Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Eﬀect of VECS on climbing time in modiﬁed forced
swimming test. All bars represent mean values with vertical lines
indicating SEM. Number of animals = 6. ∗P<. 05 versus group 2.
(1, Saline-treated group; 2, Steptozotocin-treated group; 3, VECS-
trested group; 4, FMCS-treated group; and 5, SV-treated group).
2.7. Statistical Analysis. T h ed a t aw e r ee x p r e s s e da sm e a n±
standard error of mean (SEM) and results were analyzed by
ANOVAfollowedbyDunnett’st test.TheP-valueof<.05was
considered signiﬁcant.
3.Results
3.1. Serum Glucose Levels in Rats. A signiﬁcant reduction in
blood glucoselevelswas seen when VECS (4mL ofVECS per
day) was given to diabetic rats. The same doses of FMCS
and SV did not signiﬁcantly alter the glucose levels alone
(Table 1).
3.2. Serum Insulin Levels in Rats. Table 2 depicts the
serum insulin levels. Streptozotocin signiﬁcantly reduced
the insulin concentration. Treatment with SV had no eﬀect
on streptozotocin-induced reduction. However, the levels of
serum insulin signiﬁcantly increased after administration of
VECS (16.69 ± 3.3IUmL−1; P<. 05) and FMCS (15.57 ±
2.1IUmL−1; P<. 05).
3.3. Modiﬁed Forced Swimming Test in Rats. There was a
signiﬁcant decrease in climbing behavior in diabetic rats.
On the contrary, VECS increased climbing duration to
levels similar to those of non-diabetic animals (Figure 1).
No signiﬁcant change in climbing behavior was observed
with the treatments of FMCS and SV alone. At the same
time,VECSincreasedswimming indiabeticratssigniﬁcantly.
FMCS also increased swimming. However, the same result
did not occur in the SV-treated group (Figure 2). There
was a subsequent reduction in immobility time with VECS
treatment, whereas same doses of SV did not reduce immo-
bility signiﬁcantly. Figure 3 shows that VECS and FMCS
signiﬁcantly decreased the immobility of diabetic rats in
comparison with diabetic rats and the SV-treated group.
However, only VECS decreased immobility to the same level
seen in non-diabetic rats (P<. 01).
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Figure 2: Eﬀect of VECS on swimming time in modiﬁed forced
swimming test. All bars represent mean values with vertical lines
indicating SEM. Number of animals = 6. ∗P<. 05 and ∗∗P<. 01
versus group 2. (1, Saline-treated group; 2, Steptozotocin-treated
group; 3, VECS-trested group; 4, FMCS-treated group; and 5, SV-
treated group).
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Figure 3: Eﬀect of VECS on duration of immobility. All bars
represent mean values with vertical lines indicating SEM. Number
of animals = 6. ∗P<. 05 and ∗∗P<. 001 versus group 2.
(1, Saline-treated group; 2, Steptozotocin-treated group; 3, VECS-
trested group; 4, FMCS-treated group; and 5, SV-treated group).
4.Discussionand Conclusion
The presence of clinical depression and elevated depres-
sive symptoms are higher among persons with diabetes
compared with the general population. These associations
may be related to increased risk of depressive symptoms in
individuals with diabetes, increased risk of type 2 diabetes
in individuals with depressive symptoms, or both [29, 30].
The mechanisms involved in depression are still a matter
of extensive debate. Diabetes-associated depression could
be related to the changes in the quality of life imposed
by the chronic illness and/or its treatment, or may be
a consequence of neurochemical changes induced by the
disease. Studies have shown that streptozotocin-induced
diabetes unbalances γ-aminobutyric acid, noradrenaline,
serotonin and monoamine metabolite concentration in the
ventromedial hypothalamus [31].
The present study characterizes the eﬀect of a fermented
fungus of C. sinensis rich in vanadium in a modiﬁed forced4 Evidence-Based Complementary and Alternative Medicine
Vanadium
Imitate action of insulin
Improvement
in mood
Glycemic
control
Antidepressant-like
eﬀect
Increases serum insulin concentration and
decreased serum fructosamine concentration
Cordyceps sinensis
Alterations in the noradrenergic
and dopaminergic systems
Figure 4: Diagram illustrating processing scheme of contemporary treatement approach of Vanadium and Cordyceps sinensis toward both
diabetes and depression.
swimming test model of depression using streptozotocin-
induced diabetic rats. Due to its chemical properties, in
particular its greater stability, streptozotocin is the agent of
choice for reproducible induction of a diabetic metabolic
statein experimental animals. Streptozotocininhibits insulin
secretion and causes a state of insulin-dependent diabetes
mellitus [32]. Streptozotocin-induced diabetic rats prema-
turely and repeatedly present more intense immobility in the
forced swimming test, demonstrating their susceptibility to
behavioral alterations in this animal model [33].
This is the ﬁrst study reporting the antidepressant eﬀects
of fermented C. sinensis rich in vanadium on a modiﬁed
forced swimming test, which is accepted as an animal model
ofdepressionduetoitsverygoodfaceandpredictivevalidity.
The hypoglycemic eﬀect of the fermented C. sinensis
rich in vanadium is in agreement with other similar reports
[34]. It implies that the hypoglycemic eﬀect on the hyper-
glycemic rats was caused by the co-eﬀect of C. sinensis
and vanadium (Figure 4). Vanadium is known to act as a
potent insulin mimetic agent by increasing glucose transport
and metabolism in skeletal muscle, liver and adipose tissue
[35]. Fermented C. sinensis improved the diabetes-induced
decrease in serum insulin concentration and attenuated the
diabetes-induced increases in blood glucose concentrations
[36].
Streptozotocin-induced diabetic rats prematurely and
repeatedly present more intense immobility in the forced
swimming test, demonstrating their susceptibility to behav-
ioral alterations in this animal model. The results described
herein demonstrate a signiﬁcant decrease in immobility with
a corresponding increase in the swimming and climbing
behavior following VECS treatment (Figures 1, 2,a n d3).
It is likely that the mechanism of the antidepressant
eﬀect of VECS is related to the co-eﬀect of C. sinensis and
vanadium (Figure 4). Poor glycemic control may adversely
aﬀect mood and thereby reinforce the relationship between
diabetes and depression [37]. Some studies have shown the
hypoglycemicfunctionsofvanadiumbyinsulinmimicry[38,
39]. The improved metabolic controlcan improve mood and
that insulin mimicry may have further, favorable eﬀects on
treatment satisfaction and mood [40]. Cordyceps sinensis has
an antidepressant-like activity and some of its constituents
might act as adrenoceptor and dopamine D2 receptor ago-
nists or noradrenaline/dopamine reuptake inhibitors [41].
Both hypoglycemic activity and antidepressant eﬀect were
caused by the co-eﬀect of C. sinensis and vanadium. Neither
C. sinensis nor vanadium could have antidepressant eﬀect
when given to the hyperglycemic rats singly.
In summary, this study has demonstrated that C. sinensis
rich in vanadium has an antidepressant-like activity in
streptozotocin-induced diabetic rats. It is a contemporary
treatment approach that advocates an aggressive stance
toward both diabetes and depression management.
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